{"status":"OK","data":{"id":39347,"identifier":"SGKIMW","persistentUrl":"https://doi.org/10.34894/SGKIMW","protocol":"doi","authority":"10.34894","separator":"/","publisher":"DataverseNL","publicationDate":"2020-10-26","storageIdentifier":"surf://10.34894/SGKIMW","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":9996,"datasetType":"dataset","locks":[],"latestVersion":{"id":9926,"datasetId":39347,"datasetPersistentId":"doi:10.34894/SGKIMW","datasetType":"dataset","storageIdentifier":"surf://10.34894/SGKIMW","versionNumber":3,"internalVersionNumber":5,"versionMinorNumber":1,"versionState":"RELEASED","latestVersionPublishingState":"RELEASED","deaccessionLink":"","lastUpdateTime":"2021-11-30T13:34:19Z","releaseTime":"2021-11-30T13:34:19Z","createTime":"2021-11-30T13:33:59Z","publicationDate":"2020-10-26","citationDate":"2020-10-26","effectiveDatasetFileCountLimit":10000,"datasetFileUploadsAvailable":9996,"fileAccessRequest":true,"metadataBlocks":{"citation":{"displayName":"Citation Metadata","name":"citation","fields":[{"typeName":"title","multiple":false,"typeClass":"primitive","value":"The effect of Four Approaches to treat Actinic Keratosis on the HRQoL"},{"typeName":"alternativeURL","multiple":false,"typeClass":"primitive","value":"https://hdl.handle.net/21.12109/P000000164C000000001"},{"typeName":"author","multiple":true,"typeClass":"compound","value":[{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Ahmady, Shima"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Jansen, Maud"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Nelemans, Patty"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Essers, Brigitte"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Kessels, Janneke"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Kelleners-Smeets, Nicole"}},{"authorName":{"typeName":"authorName","multiple":false,"typeClass":"primitive","value":"Mosterd, Klara"}}]},{"typeName":"datasetContact","multiple":true,"typeClass":"compound","value":[{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Neyens, Wendy"}},{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Mosterd, Klara"}},{"datasetContactName":{"typeName":"datasetContactName","multiple":false,"typeClass":"primitive","value":"Ahmady, Shima"}}]},{"typeName":"dsDescription","multiple":true,"typeClass":"compound","value":[{"dsDescriptionValue":{"typeName":"dsDescriptionValue","multiple":false,"typeClass":"primitive","value":"To evaluate the impact of actinic keratosis (AK) and the effect of four AK treatments on the health-related quality of life (HRQoL), the Skindex-29 and AKQoL questionnaires were completed by 624 patients with AK participating in a randomized controlled trial (RCT) comparing 5% fluorouracil-cream, 5% imiquimod-cream, methyl-aminolevulinate photodynamic therapy (MAL-PDT), and 0.015% ingenol mebutate gel. Patients completed the questionnaires at baseline and 12 months post-treatment."}}]},{"typeName":"subject","multiple":true,"typeClass":"controlledVocabulary","value":["Medicine, Health and Life Sciences"]},{"typeName":"keyword","multiple":true,"typeClass":"compound","value":[{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"skin"},"keywordVocabulary":{"typeName":"keywordVocabulary","multiple":false,"typeClass":"primitive","value":"efo"},"keywordVocabularyURI":{"typeName":"keywordVocabularyURI","multiple":false,"typeClass":"primitive","value":"http://www.ebi.ac.uk/efo/EFO_0000962"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"actinic keratosis"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Homo sapiens"},"keywordVocabulary":{"typeName":"keywordVocabulary","multiple":false,"typeClass":"primitive","value":"ncbitaxon"},"keywordVocabularyURI":{"typeName":"keywordVocabularyURI","multiple":false,"typeClass":"primitive","value":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"Topical Ingenol mebutate"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"5% 5-fluorouracil"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"5% Imiquimod"}},{"keywordValue":{"typeName":"keywordValue","multiple":false,"typeClass":"primitive","value":"photodynamic therapy"}}]},{"typeName":"depositor","multiple":false,"typeClass":"primitive","value":"Wendy Neyens"},{"typeName":"dateOfDeposit","multiple":false,"typeClass":"primitive","value":"2020-10-22"}]},"dansDataVaultMetadata":{"displayName":"Data Vault Metadata","name":"dansDataVaultMetadata","fields":[{"typeName":"dansDataversePid","multiple":false,"typeClass":"primitive","value":"doi:10.34894/SGKIMW"},{"typeName":"dansDataversePidVersion","multiple":false,"typeClass":"primitive","value":"3.1"},{"typeName":"dansBagId","multiple":false,"typeClass":"primitive","value":"urn:uuid:ec99d2f0-fb9a-4e55-ba5b-0b60db5b4bd2"},{"typeName":"dansNbn","multiple":false,"typeClass":"primitive","value":"urn:nbn:nl:ui:13-1bf3226a-29c7-4839-9e71-885d34e2686b"}]}},"files":[{"label":"AKTI_MACRO_- QoL Skindex en AKQoL_WeNe_21OCT2020.csv","restricted":true,"version":1,"datasetVersionId":9926,"dataFile":{"id":39720,"persistentId":"","filename":"AKTI_MACRO_- QoL Skindex en AKQoL_WeNe_21OCT2020.csv","contentType":"text/csv","friendlyType":"Comma Separated Values","filesize":110390,"storageIdentifier":"surf://store:1758da5ce4d-3dca6028f499","rootDataFileId":-1,"checksum":{"type":"SHA-1","value":"0f339f899661a9a40cd1d09b5059e8dbe2e8cb9d"},"tabularData":false,"creationDate":"2020-11-03","publicationDate":"2020-11-03","lastUpdateTime":"2021-11-30T13:34:19Z","fileAccessRequest":true}},{"description":"","label":"AKTI_Subset_codebook_metadata_WeNe_21OCT2020.xlsx","restricted":true,"directoryLabel":"AKTI_.Actinic_Keratosis_Topical_Ingenol_Mebutate._trial__Metadata_of_Skindex_and_AKQoL_scores_at_baseline_and_12_months","version":1,"datasetVersionId":9926,"dataFile":{"id":39349,"persistentId":"","filename":"AKTI_Subset_codebook_metadata_WeNe_21OCT2020.xlsx","contentType":"application/vnd.openxmlformats-officedocument.spreadsheetml.sheet","friendlyType":"MS Excel Spreadsheet","filesize":14146,"description":"","storageIdentifier":"surf://store:1756462cb78-d1efbe2af560","rootDataFileId":-1,"checksum":{"type":"SHA-1","value":"2d87179b6c2d5a4e9c8c9d1f4d4d4063ad140abb"},"tabularData":false,"creationDate":"2020-10-26","publicationDate":"2020-10-26","directoryLabel":"AKTI_.Actinic_Keratosis_Topical_Ingenol_Mebutate._trial__Metadata_of_Skindex_and_AKQoL_scores_at_baseline_and_12_months","lastUpdateTime":"2021-11-30T13:34:19Z","fileAccessRequest":true}},{"label":"metadata.xml","restricted":true,"version":1,"datasetVersionId":9926,"dataFile":{"id":40104,"persistentId":"","filename":"metadata.xml","contentType":"text/xml","friendlyType":"XML","filesize":1670,"storageIdentifier":"surf://store:17592ed1000-85db416b913c","rootDataFileId":-1,"checksum":{"type":"SHA-1","value":"cb571a23545f73a8591d168bc779caf602c8b7a8"},"tabularData":false,"creationDate":"2020-11-04","publicationDate":"2020-11-04","lastUpdateTime":"2021-11-30T13:34:19Z","fileAccessRequest":true}}]}}}